No abstract available
MeSH terms
-
Blood Coagulation Disorders / epidemiology*
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines* / adverse effects
-
COVID-19 Vaccines* / immunology
-
ChAdOx1 nCoV-19
-
Clinical Trials, Phase III as Topic
-
Drug Industry
-
Europe
-
Humans
-
Immunization Programs
-
Immunogenicity, Vaccine
-
United States
Substances
-
COVID-19 Vaccines
-
ChAdOx1 nCoV-19